نتایج جستجو برای: teriflunomide

تعداد نتایج: 247  

2017
Narges Dargahi Maria Katsara Theodore Tselios Maria-Eleni Androutsou Maximilian de Courten John Matsoukas Vasso Apostolopoulos

The treatment of multiple sclerosis (MS) has changed over the last 20 years. All immunotherapeutic drugs target relapsing remitting MS (RRMS) and it still remains a medical challenge in MS to develop a treatment for progressive forms. The most common injectable disease-modifying therapies in RRMS include β-interferons 1a or 1b and glatiramer acetate. However, one of the major challenges of inje...

Journal: :International Journal of Pharmacy and Pharmaceutical Sciences 2019

2013
Alireza Minagar

With the introduction of interferon- β 1b in 1993 as the first FDA-approved treatment for multiple sclerosis, the era of treatment of this incurable disease began, and its natural course was permanently changed. Currently, seven different treatments for patients with multiple sclerosis with different mechanisms of action and dissimilar side effect profiles exist. These medications include inter...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید